Publications

Detailed Information

Angular Dihydropyranocoumarins from Peucedanum japonicum Roots

DC Field Value Language
dc.contributor.advisor김진웅-
dc.contributor.author홍민지-
dc.date.accessioned2017-10-27T17:00:54Z-
dc.date.available2017-10-27T17:00:54Z-
dc.date.issued2017-08-
dc.identifier.other000000145736-
dc.identifier.urihttps://hdl.handle.net/10371/137015-
dc.description학위논문 (박사)-- 서울대학교 대학원 약학대학 약학과, 2017. 8. 김진웅.-
dc.description.abstractPeucedanum japonicum Thunberg, belongs to Umbelliferae family, was distributed in southern and eastern Asian countries. Its roots were traditionally used as a medicine for cold and neuralgic diseases in Korea and Taiwan.
It was reported that the roots of this plant contained coumarins, chromones, polyacetylenes, sugar alcohols, and steroid glycosides. Pharmacological researches revealed that P. japonicum roots showed antioxidative, anti-inflammatory, antifungal activity and cytotoxic effect against lymphocytic leukaemia.
In this study, sixteen new angular dihydropyranocoumarins (1-16) and three new angular monohydromonohydroxyfuranocoumarins (41-43) were isolated along with forty-five known compounds from the n-hexane and CHCl3 fractions of the P. japonicum roots. The known compounds were characterized as angular dihydropyranocoumarins (17-40), linear furanocoumarins (44-47), an angular dihydrofuranocoumarin (48), a linear dihydropyranocoumarin (49), simple coumarins (50-58), a chromone (59), ferulic acid derivatives (60-61), a lignan (62), a phenylpropanoid (63), and an indole alkaloid (64).
Isolated angular dihydropyranocoumarins (khellactones) included monoacyl- and diacyl-type khellactone esters. In the case of monoacylkhellactones, the absolute configuration was easily determined by the Mosher method. However, the absolute configuration of diacyl khellactone esters was difficult to assign due to the absence of free hydroxyl group. Therefore, partial alkaline hydrolysis prior to MTPA derivatization and X-ray diffraction analysis were applied to determine the absolute configurations at 3- and 4-positions. Because the success of partial hydrolysis and single crystallization was very difficult, ECD spectroscopy was suggested to confirm the absolute configuration of most of the compounds.
Interestingly, a few enantiomers were discovered and isolated by enantio-selective column. Enantiomers were usually detected and isolated using chiral column. However, RP-HPLC analysis with MTPA reaction products could be alternative method to confirm enantiomer existence without testing a number of chiral-selective columns. In the case of cis-monoacylkhellactones, the interconversion of substituents at 3- and 4-position was observed. The major MS fragment peak of khellactone esters was detected without a C-4 substituent. Thus, the position of substituents at 3 and 4 could be determined by MS fragmentation analysis without HMBC measurement.
The NO production inhibitory activity of isolated compounds were tested using Griess assay in LPS-induced RAW264.7 cells. As a result, 1, 3-6, 22, 31, and 36-38 showed significant activity without cytotoxicity. The isobutyryl, senecioyl, 2-methylbutyryl, and isovaleryl moieties at 3 position played more important role than the acetyl and angeloyl groups.
In conclusion, the absolute configuration of isolated compounds were assigned by various methods. Those methods will become useful guide to solve similar structures. The isolated compounds which significantly inhibited NO production were suggested as anti-inflammatory candidates from natural resources.
-
dc.description.tableofcontentsChapter 1. Introduction 1
1.1. Study Background 1
1.1.1. The genus Peucedanum and the species Peucedanum japonicum Thunberg 1
1.1.2. Angular dihydropyranocoumarins 4
1.1.3. Inflammation and the role of nitric oxide 4
1.2. Purpose of research 5
Chapter 2. Structure Elucidation of Khellactone Esters 6
2.1. Compound 1 6
2.2. Compound 2 10
2.3. Compound 9 13
2.4. Compounds 8, 10, 11, and 15 15
2.5. Compound 6 19
2.6. Compounds 3, 4, 7, and 13 20
2.7. Compounds 5, 21, 22, and 23 23
2.8. Compounds 12, 24, 25, 26, 27, and 40 26
2.9. Compounds 14, 28, 29, and 30 31
2.10. Compounds 31, 32, 33, and 34 34
2.11. Compounds 35, 36, and 37 37
2.12. Compounds 38 and 39 39
2.13. Compounds 16, 17, 18, 19, and 20 41
Chapter 3. Structure Elucidation of Angular Furanocoumarins 48
3.1. Compounds 41, 42 and 43 48
3.2. Compound 48 54
Chapter 4. Structure Elucidation of Other Compounds 55
4.1. Compound 44 55
4.2. Compounds 45, 46, and 47 56
4.3. Compound 49 58
4.4. Compounds 50 and 51 59
4.5. Compounds 52, 53, 54, and 55 61
4.6. Compounds 56, 57, and 58 64
4.7. Compound 59 66
4.8. Compounds 60 and 61 67
4.9. Compound 62 69
4.10. Compound 63 70
4.11. Compound 64 71
Chapter 5. Remark 74
5.1. Acyl migration 74
5.2. MS fragmentation 76
Chapter 6. Bioactivity of the Isolated Compounds 78
6.1. NO production inhibitory activity of isolated compounds 78
Chapter 7. Experimental Section 79
7.1. Materials 79
7.1.1. Plant material. 79
7.1.2. Reagents 79
7.1.3. Equipments 79
7.2. Extraction and fractionation of P. japonicum 81
7.3. Isolation of compounds from n-hexane and CHCl3 fractions 82
7.4. Spectroscopic and spectrometric data of isolated compounds 87
7.4.1. (3S,4S)-3'-O-isobutyryl-4'-O-(2-methylbutyryl)khellactone (1) 87
7.4.2. (3S,4S)-3'-O-acetyl-4'-O-senecioylkhellactone (2). 87
7.4.3. (3S,4S)-4'-O-isobutyryl-3'-O-(2-methylbutyryl)khellactone (3) 87
7.4.4. (3S,4S)-3'-O-(2-methylbutyryl)-4'-O-senecioylkhellactone (4) 88
7.4.5. (3S,4S)-4'-O-(2-methylbutyryl)-3'-O-senecioylkhellactone (5) 88
7.4.6. (3S,4S)-3'-O-isobutyryl-4'-O-isovalerylkhellactone (6) 89
7.4.7. (3S,4S)-4'-O-angeloyl-3'-O-(2-methylbutyryl)khellactone (7) 89
7.4.8. (3S,4S)-3'-O-butyryl-4'-O-(2-methylbutyryl)khellactone (8). 89
7.4.9. (3S,4S)-4'-O-angeloyl-3'-O-isovalerylkhellactone (9) 90
7.4.10. (3S,4S)-3'-O-acetyl-4'-O-(3-hydroxyisovaleryl)khellactone (10) 90
7.4.11. (3S,4S)-3'-O-acetyl-4'-O-(3-hydroxy-2-methylbutyryl)khellactone (11) 90
7.4.12. (3S,4S)-3'-O-acetyl-4'-O-(2-methylbutyryl)khellactone (12) 91
7.4.13. (3S,4S)-3'-O-(2-methylbutyryl)khellactone (13) 91
7.4.14. (3S,4S)-4'-O-(2-methylbutyryl)khellactone (14) 91
7.4.15. (3S,4S)-4'-O-methyl-3'-O-(2-methylbutyryl)khellactone (15) 92
7.4.16. (3S,4R)-4'-O-senecioylkhellactone (16) 92
7.4.17. (3S,4S)-4'-O-senecioylkhellactone (17) 92
7.4.18. (3R,4R)-4'-O-senecioylkhellactone (18) 93
7.4.19. (3S,4S)-3'-O-senecioylkhellactone (19) 93
7.4.20. (3R,4R)-3'-O-senecioylkhellactone (20) 93
7.4.21. (3S,4S)- 4'-O-angeloyl-3'-O-senecioylkhellactone (21) 94
7.4.22. (3S,4S)- 3',4'-di-O-senecioylkhellactone (22) 94
7.4.23. (3S,4S)-4'-O-isovaleryl-3'-O-senecioylkhellactone (23) 95
7.4.24. (3S,4S)-3'-O-acetylkhellactone (24) 95
7.4.25. (3S,4S)- 3-O-acetyl-4-O-angeloylkhellactone (25) 95
7.4.26. (3S,4S)-3'-O-acetyl-4'-O-isobutyrylkhellactone (26) 96
7.4.27. (3S,4S)-3'-O-acetyl-3'-O-isovalerylkhellactone (27) 96
7.4.28. (-)-cis-khellactone (28) 96
7.4.29. (3S,4S)-4'-O-acetylkhellactone (29) 97
7.4.30. (3S,4S)-3-hydroxy-4-O-angeloyloxy-3,4-dihydroseelin (30) 97
7.4.31. (3S,4S)-3'-O-angeloyl-4'-O-(2-methylbutyryl)khellactone (31) 97
7.4.32. (3S,4S)-3',4'-di-O-angeloylkhellactone (32) 98
7.4.33. (3S,4S)-3-O-angeloyloxy-4-hydroxy-3,4-dihydroseselin (33) 98
7.4.34. (3S,4S)-3-O-angeloyl-4-O-senecioylkhellactone (34) 98
7.4.35. (3S,4S)-3'-O-isovaleryl-4'-O-senecioylkhellactone (35) 99
7.4.36. (3S,4S)-3',4'-di-O-isovalerylkhellactone (36) 99
7.4.37. (3S,4S)-3'-O-isovaleryl-4'-O-(2-methylbutyryl)khellactone (37) 99
7.4.38. (3R)-O-senecioyllomatin (38) 100
7.4.39. (3R)-O-isovaleroyllomatin (39) 100
7.4.40. (3R,4R)-3,4-di-O-acetylkhellactone (40) 100
7.4.41. 2-hydroxy-3-O-senecioylvaginol (41) 101
7.4.42. 2-hydroxy-3-O-(2-methylbutyryl)vaginol (42) 101
7.4.43. 2-hydroxy-3-O-isovalerylvaginol (43) 101
7.4.44. (+)-marmesin (nodakenetin) (44) 102
7.4.45. 9-(2-hydroxy-3-methoxy-3-methylbutoxy)bergapten (45) 102
7.4.46. isoimperatorin (46) 103
7.4.47. 5-(2-hydroxy-3-methoxy-3-methylbutoxy)psoralen (47) 103
7.4.48. 3-O-senecioylvaginidiol (48) 104
7.4.49. (S)-(+)-decursin (49) 104
7.4.50. isoarnottinin (50) 105
7.4.51. umbelliferone (51) 105
7.4.52. scoparone (52) 106
7.4.53. tamarin (isosuberenol) (53) 106
7.4.54. (Z)-suberenol (54) 106
7.4.55. suberosin (55) 107
7.4.56. peucedanol (56) 107
7.4.57. peucedanol 7-O-β-D-glucopyranoside (57) 108
7.4.58. peujaponiside (58) 108
7.4.59. eugenin (59) 109
7.4.60. 6,β-dihydroxyphenethyl trans-ferulate (decursidate) (60) 109
7.4.61. 6-hydroxyphenethyl cis-ferulate (61) 110
7.4.62. (-)-pinoresinol (62) 110
7.4.63. trans-ferulic acid (63) 111
7.4.64. 3-formylindole (64) 111
7.5. Partial and total alkaline hydrolysis of 1 123
7.6. Preparation of MTPA esters of 1a 123
7.7. Preparation of MTPA esters of 16 124
7.8. Preparation of MTPA esters of 17 and 18 125
7.9. Preparation of MTPA esters of 19 and 20 125
7.10. X-ray crystallographic analysis of 1 and 2 127
7.10.1. Crystal data of 1 127
7.10.2. Crystal data of 2 127
7.11. ECD calculation 128
7.12. Evaluation of inhibitory effect on NO production in LPS-stimulated RAW 264.7 cells 129
7.12.1. Reagents 129
7.12.2. Cell cultures 129
7.12.3. Griess assay 129
7.12.4. MTT assay 130
Chapter 8. Conclusion 131
References 133
국문초록 140
-
dc.formatapplication/pdf-
dc.format.extent4765167 bytes-
dc.format.mediumapplication/pdf-
dc.language.isoen-
dc.publisher서울대학교 대학원-
dc.subjectPeucedanum japonicum-
dc.subjectangular dihydropyranocoumarins-
dc.subjectkhellactone esters-
dc.subjectpartial hydrolysis-
dc.subjectX-ray crystallography-
dc.subjectand Circular dichroism (CD)-
dc.subject.ddc615-
dc.titleAngular Dihydropyranocoumarins from Peucedanum japonicum Roots-
dc.typeThesis-
dc.description.degreeDoctor-
dc.contributor.affiliation약학대학 약학과-
dc.date.awarded2017-08-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share